ArticleFrontiers in pharmacology2022

The iron-modulating hormone hepcidin is upregulated and associated with poor survival outcomes in renal clear cell carcinoma.

Jian Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.